WELCOME TO SIT ITALIA

copertina SIT Press Release

Sit Acquires Sulmetin Fom Sanofi

SIT Group is pleased to announce the acquisition of established product SULMETIN from Sanofi, as a result of the agreement signed on November 8, 2022. 

This additional acquisition in Spain market increases DESMA Spain’s footprint and business. 

SIT PHARMA is pleased to announce the acquisition of OSTIDIL-D3 and KEFORAL
SIT Pharma is pleased to announce the acquisition of DERINOX® from Therabel Lucien Pharma Sas
SIT Pharma is pleased to announce the acquisition of MIZOLLEN® from THERABEL HEALTHCARE LIMITED